A, K., JV, B., V, P., & R, K. (2026). Comparative pooled analysis of targeted therapies, or immunotherapy plus chemotherapies versus conventional platinum-based therapies or single-agent immunotherapies in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 32(5), 916. https://doi.org/10.1177/10781552251383925
Chicago Style (17th ed.) CitationA, Khadela, Beladiya JV, Patel V, and Kothari R. "Comparative Pooled Analysis of Targeted Therapies, or Immunotherapy Plus Chemotherapies Versus Conventional Platinum-based Therapies or Single-agent Immunotherapies in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 32, no. 5 (2026): 916. https://doi.org/10.1177/10781552251383925.
MLA (9th ed.) CitationA, Khadela, et al. "Comparative Pooled Analysis of Targeted Therapies, or Immunotherapy Plus Chemotherapies Versus Conventional Platinum-based Therapies or Single-agent Immunotherapies in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 32, no. 5, 2026, p. 916, https://doi.org/10.1177/10781552251383925.